- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Lenalidomide – July 2011
Lenalidomide, capsules, 5 mg and 10 mg, Revlimid® - July 2011
Last updated
28 October 2011